Gao V, Crawford CV, Burré J.
2025.
Corrigendum: The Gut-Brain Axis in Parkinson's Disease.. Cold Spring Harb Perspect Med.
Gan L, Cookson MR, Petrucelli L, La Spada AR.
2018.
Converging pathways in neurodegeneration, from genetics to mechanisms.. Nat Neurosci. 21(10):1300-1309.
Naseri NN, Wang H, Guo J, Sharma M, Luo W.
2019.
The complexity of tau in Alzheimer's disease.. Neurosci Lett. 705:183-194.
Pranski EL, Van Sanford CD, Dalal NV, Orr AL, Karmali D, Cooper DS, Costa N, Heilman CJ, Gearing M, Lah JJ et al..
2012.
Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain.. Neurosci Lett. 520(1):104-9.
DeMattos RB, O'dell MA, Parsadanian M, Taylor JW, Harmony JAK, Bales KR, Paul SM, Aronow BJ, Holtzman DM.
2002.
Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.. Proc Natl Acad Sci U S A. 99(16):10843-8.
Bales KR, Tzavara ET, Wu S, Wade MR, Bymaster FP, Paul SM, Nomikos GG.
2006.
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody.. J Clin Invest. 116(3):825-32.
Pfau SJ, Langen UH, Fisher TM, Prakash I, Nagpurwala F, Lozoya RA, Lee W-CAllen, Wu Z, Gu C.
2024.
Characteristics of blood-brain barrier heterogeneity between brain regions revealed by profiling vascular and perivascular cells.. Nat Neurosci. 27(10):1892-1903.
Benharouga M, Sharma M, Lukacs GL.
2002.
CFTR folding and maturation in cells.. Methods Mol Med. 70:229-43.
Bravo CParra, Naguib SA, Gan L.
2024.
Cellular and pathological functions of tau.. Nat Rev Mol Cell Biol. 25(11):845-864.
Bateup HS, Svenningsson P, Kuroiwa M, Gong S, Nishi A, Heintz N, Greengard P.
2008.
Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs.. Nat Neurosci. 11(8):932-9.
Burré J, Sharma M, Südhof TC.
2018.
Cell Biology and Pathophysiology of α-Synuclein.. Cold Spring Harb Perspect Med. 8(3)